Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and fiscal year ended March 31, 2021
Filing Date: May 14, 2021
This filing serves to furnish the U.S. Securities and Exchange Commission with public disclosures regarding the company's results of operations and financial condition for the specified period. The results are reported under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS).
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity.
Available Data Sources Referenced:
- IFRS Audited Consolidated Financial Results (Exhibit 99.2)
- Ind AS Audited Consolidated Financial Results (Exhibit 99.3)
- Ind AS Audited Standalone Financial Results (Exhibit 99.4)
- Press Release: "Dr. Reddy's Q4 FY21 Financial Results" (Exhibit 99.1)
Investors must refer to the attached exhibits or the company website (www.drreddys.com) for specific financial figures.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the quarter and year ended March 31, 2021, have been announced and attached.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It strictly functions as a notification of the availability of audited financial results and a press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for management's discussion of Q4 FY21 performance.
- Analyze Exhibit 99.2 for IFRS-based consolidated revenue and profit figures.
- Compare IFRS results with Exhibit 99.3 (Ind AS) to understand accounting standard variances.
- Verify the standalone financial health of the parent entity via Exhibit 99.4.
- Confirm the audit status of the attached financial statements as indicated in the filing.